Skip to content
OpenCapital
Get started

Kymera Therapeutics KYMR Enterprise value

Enterprise value at other companies

Pfizer logo
PfizerPFE
$222.4B+9.2%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$622.06B+50.5%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$81.42B+18.1%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$8.16B+187%
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
$7.06B+44.2%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$6.54B+130%

Other financials

Income statement

See full
Revenue$34.4M+55.5%
Operating income-$84.2M-13.1%
Net income-$69.2M-5.6%
EPS (diluted)-$0.71+13.4%

Balance sheet

See full
Cash & equivalents$144.1M+60.2%
Total debt$82.2M-6.5%
Total equity$1.5B+95.8%
Total assets$1.7B+81.7%

Cash flow

See full
Operating cash flow-$88.8M-12.2%
CapEx$434.0K-7.1%
Free cash flow-$89.3M-12.1%

Valuation

See full
Market cap$7.44B+283%
P/S144.5×+111×

Profitability

See full
Operating margin-697.7%+635pp
Net margin-612%+602pp
FCF margin-474%+92.4pp

Returns & leverage

See full
Return on equity-27.1%-3.7pp
Debt / equity0.1×-0.1×
Current ratio10.8×+2.3×

Where this comes from

Calculated from Kymera Therapeutics’s reported figures.

$6.8Bmarket cap+$82.2Mtotal debt−$144.1Mcash and equivalents=$6.74B

The official record: Kymera Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kymera Therapeutics's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kymera Therapeutics's enterprise value?
Kymera Therapeutics (KYMR) reported enterprise value of $6.74B in Q1 2026.
How has Kymera Therapeutics's enterprise value changed year-over-year?
Kymera Therapeutics's enterprise value increased by 279.5% year-over-year, from $1.78B to $6.74B.
What is the long-term trend for Kymera Therapeutics's enterprise value?
Over 5 years (2020 to 2025), Kymera Therapeutics's enterprise value has grown at a 16.6% compound annual growth rate (CAGR), from $2.76B to $5.95B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.